Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe

Pharmazie

Volumn 64, Issue 4, 2009, Pages 227-231

  Sancheti, P P ^a   Karekar, P ^a   Vyas, V M ^a   Shah, M ^a   Pore, Yogesh ^a  

^a Government College of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; PLURONIC 188; POLOXAMER; SURFACTANT; UNCLASSIFIED DRUG; AZETIDINE DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; X RAY DIFFRACTION; CHEMISTRY; KINETICS; SOLUBILITY;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CALORIMETRY, DIFFERENTIAL SCANNING; KINETICS; POLOXAMER; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS; X-RAY DIFFRACTION;

EID: 66449113126     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.8331     Document Type: Article

References (28)

1. Chen Y, Zhang GGZ, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD (2004) Int J Pharm 286: 69-80.
2. Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60: 1281-1302.
3. Corrigan OI, Holohan EM, Reilly MR (1985) Physicochemical properties of indomethacin and related compound co-spray dried with polyvinyl pyrrolidone. Drug Dev Ind Pharm 11: 677-695.
4. Craig DQM (2002) The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 231: 131-144.
5. Dissolution methods for drug products; U.S. Food and drug administration Available via http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp- SearchResults-Dissolutions.cfm?PrintAll=1. Accessed 24 Aug 2007.
6. Erlandsson B (2002) Stability-indicating changes in poloxamers: the degradation of ethylene oxidepropyleneoxide block copolymers at 25 and 40 °C. Polymer Degrad Stabil 78: 571-575.
7. Ford JL (1986) The current status of solid dispersions. Pharm Acta Helv 61: 69-88.
8. Geneidi AS, Ali AA, Salama RB (1978) Solid dispersions of nitrofurantoin, ethotoin and coumarin with polyethylene glycol 6000 and other coprecipitates with povidone 25000. J Pharm Sci 67: 114-116.
9. Ghebremeskel AN, Vemavarapu C, Lodaya M (2007) Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer surfactant combinations using solubility parameters and testing the processability. Int J Pharm 328: 119-129.
10. Judith A, Tamas K, Guy S, Ori L, Reuven I (2006) Eztimibe polymorphs, US Patent 20060160785.
11. Kabanov AV, Lemieux P, Vinogradov S, Alakhov V (2002) Pluronic® block copolymers: novel functional molecules for gene therapy. Adv Drug Del Rev 54: 223-233.
12. Khan KA (1975) The concept of dissolution efficiency. J Pharm Pharmacol 27: 48-49.
13. Kim EJ, Chun MK, Jang JS (2006) Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm 64: 200-205.
14. Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50: 47-60.
15. Mooter G, Augustijns P, Blaton N, Kinget R (1998) Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 164: 67-80.
16. Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK, Woo JS, Lyoo WS, Yong CS, Choi HG ( 2007) Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with pluronic 188. Int J Pharm 343: 228-237.
17. Patel R, Bhimani D, Patel J, Patel DJ (2008) Solid-state characterization and dissolution properties of ezetimibe-cyclodextrins inclusion complexes. J Incl Phenom Macrocycl Chem 60: 241-251
18. Proudfoot S (1991) Factors affecting bioavailability: factors influencing drug absorption from gastrointestinal tract. In: Aulton ME (ed.) Pharmaceutics: The Science of Dosage Form Design, Edinburgh: Churchil Livingstone, p. 135-173.
19. Ruan LP, Yu BY, Fu GM, Zhu D (2005) Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal 38: 457-464.
20. Ryan JA (1986) Compressed pellet x-ray diffraction monitoring for optimisation of crystallinity in lyophilised solids: imipenem: cilastatin sodium case. J Pharm Sci 75: 805-807.
21. Save T, Venkitachalam P (1992) Studies on solid dispersions of nifedipine. Drug Dev Ind Pharm 18: 1663-1679.
22. Schott H, Kwan LC, Feldman S (1982) The role of surfactant in the release of very slightly soluble drugs from tablets. J Pharm Sci 71: 1038-1045.
23. Serajuddin ATM (1999) Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthrougs. J Pharm Sci 88: 1058-1066.
24. Sharma DK, Joshi SB (2007) Solubility enhancement strategies for poorly water-soluble drugs in solid dispersions: A review. Asian J Pharm 1: 9-19.
25. Singhare DS, Khan S and Yeole PG (2005) Poloxamers: Promising block co-polymers in drug delivery. Indian J Pharm Sci 67: 523-531.
26. Vytorin Description RxList.com New York: The Internet Drug Index WebMD, Inc.; c1996-2005, Available via http://www.rxlist.com/cgi/generic/vytorin.htm. Accessed 24 Aug 2008.
27. Woodlinger AM (2005) Cardiovascular drugs. In: Troy DB (ed.) Remington The science and practice of pharmacy, Philadelphia: Lippincott Williams and Wilkins, p. 1367.
28. Zhang R, Somasundaran P (2006) Advances in adsorption of surfactants and their mixtures at solid/solution interfaces. Adv Colloid Interface Sci 123: 213-229.